Collegium Pharmaceutical, Inc. Total Liabilities and Equity
Collegium Pharmaceutical, Inc. (COLL) had Total Liabilities and Equity of $2.14 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $2.14B.
- 2026-03-31: Liabilities and Equity $1.65B.
- 2025-12-31: Liabilities and Equity $1.66B.
- 2025-09-30: Liabilities and Equity $1.61B.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $2.14B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.65B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.66B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.61B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.59B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.63B 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.66B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.64B 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.05B 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.11B 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.14B 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.18B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.21B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.21B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.17B 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.20B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.25B 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.25B 10-Q · filed 2022-05-10 |
| 2021-12-31 | $692.08M 10-K · filed 2023-02-23 |
| 2021-09-30 | $741.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $713.74M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $646.07M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $643.84M 10-K · filed 2022-02-24 |
| 2020-09-30 | $643.84M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $646.87M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $634.79M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $306.30M 10-K · filed 2021-02-25 |
| 2019-09-30 | $303.98M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $301.58M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $294.36M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $291.25M 10-K · filed 2020-02-27 |
| 2018-09-30 | $646.51M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $673.33M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $696.28M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $135.57M 10-K · filed 2019-02-27 |
| 2017-09-30 | $122.67M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $124.52M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $139.85M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $162.02M 10-K · filed 2018-03-07 |
| 2016-09-30 | $98.72M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $119.72M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $136.34M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $97.72M 10-K · filed 2017-03-10 |
| 2015-09-30 | $107.05M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $114.17M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $47.39M 10-Q/A · filed 2015-07-17 |
| 2014-12-31 | $5.09M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |